Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium botulinum Putative sporulation transcription regulator WhiA (whiA) CSB-YP464722DUF
CSB-EP464722DUF
CSB-BP464722DUF
CSB-MP464722DUF
CSB-EP464722DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP464723DUF
CSB-EP464723DUF
CSB-BP464723DUF
CSB-MP464723DUF
CSB-EP464723DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L27 (rpmA) CSB-YP464724DUF
CSB-EP464724DUF
CSB-BP464724DUF
CSB-MP464724DUF
CSB-EP464724DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Probable endonuclease 4 (nfo) CSB-YP464725DUF
CSB-EP464725DUF
CSB-BP464725DUF
CSB-MP464725DUF
CSB-EP464725DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP464726DUF
CSB-EP464726DUF
CSB-BP464726DUF
CSB-MP464726DUF
CSB-EP464726DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Flagellar assembly factor FliW (fliW) CSB-YP464727DUF
CSB-EP464727DUF
CSB-BP464727DUF
CSB-MP464727DUF
CSB-EP464727DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Chaperone protein DnaK (dnaK), partial CSB-YP464728DUF
CSB-EP464728DUF
CSB-BP464728DUF
CSB-MP464728DUF
CSB-EP464728DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Potassium-transporting ATPase C chain (kdpC), partial CSB-YP464729DUF1
CSB-EP464729DUF1
CSB-BP464729DUF1
CSB-MP464729DUF1
CSB-EP464729DUF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP464730DUF
CSB-EP464730DUF
CSB-BP464730DUF
CSB-MP464730DUF
CSB-EP464730DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP464731DUF
CSB-EP464731DUF
CSB-BP464731DUF
CSB-MP464731DUF
CSB-EP464731DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP464732DUF
CSB-EP464732DUF
CSB-BP464732DUF
CSB-MP464732DUF
CSB-EP464732DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Transcriptional repressor NrdR (nrdR) CSB-YP464733DUF
CSB-EP464733DUF
CSB-BP464733DUF
CSB-MP464733DUF
CSB-EP464733DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Acetate kinase (ackA) CSB-YP464734DUF
CSB-EP464734DUF
CSB-BP464734DUF
CSB-MP464734DUF
CSB-EP464734DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Inosose dehydratase (iolE) CSB-YP464735DUF
CSB-EP464735DUF
CSB-BP464735DUF
CSB-MP464735DUF
CSB-EP464735DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum N utilization substance protein B homolog (nusB) CSB-YP464736DUF
CSB-EP464736DUF
CSB-BP464736DUF
CSB-MP464736DUF
CSB-EP464736DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP464737DUF
CSB-EP464737DUF
CSB-BP464737DUF
CSB-MP464737DUF
CSB-EP464737DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0145 protein CLH_2273 (CLH_2273) CSB-YP464738DUF
CSB-EP464738DUF
CSB-BP464738DUF
CSB-MP464738DUF
CSB-EP464738DUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurihydrogenibium sp. Undecaprenyl-diphosphatase (uppP), partial CSB-YP464739FPP1
CSB-EP464739FPP1
CSB-BP464739FPP1
CSB-MP464739FPP1
CSB-EP464739FPP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurihydrogenibium sp. Type III pantothenate kinase (coaX) CSB-YP464740FPP
CSB-EP464740FPP
CSB-BP464740FPP
CSB-MP464740FPP
CSB-EP464740FPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfurihydrogenibium sp. ATP synthase epsilon chain (atpC) CSB-YP464741FPP
CSB-EP464741FPP
CSB-BP464741FPP
CSB-MP464741FPP
CSB-EP464741FPP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>